Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
14.1M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
960K
-
Shares change
-
+960K
-
Total reported value, excl. options
-
$2.88M
-
Value change
-
+$2.88M
-
Number of buys
-
1
-
Price
-
$3.00
Significant Holders of Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GRCE) as of Q3 2024
1 filing reported holding GRCE - Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.